Thesis
Given Veeva Systems' strong quarterly performance, market sentiment, and its competitive edge in the life sciences software sector, I believe that VEEV is well-positioned for further growth. As a result, I see value in shorting the stock in anticipation of potential headwinds from rising costs and increased competition.